SCHEMBL20095590

SCHEMBL20095590

CC1CCc2cc(=O)n(C)cc2N(C)C1=O

nearest known ligand 0.43

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ RIPK1 Q13546 6/20 0.43
▸ MAPT P10636 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ ATAD2 Q6PL18 1/20 0.31
▸ BMPR1B O00238 1/20 0.31
▸ BMPR1A P36894 1/20 0.31
▸ ACVRL1 P37023 1/20 0.31
▸ ACVR1 Q04771 1/20 0.31
▸ CREBBP Q92793 2/20 0.31
▸ DRD4 P21917 2/20 0.30
▸ DRD2 P14416 1/20 0.30
▸ SRD5A1 P18405 2/20 0.30
▸ BRD4 O60885 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24094029 0.88 RIPK1 (0.43) RIPK1MAPTHPGDATAD2CREBBP
SCHEMBL21220781 0.83 RIPK1 (0.42) RIPK1ATAD2BMPR1BBMPR1AACVRL1
SCHEMBL21220899 0.83 RIPK1 (0.42) RIPK1ATAD2BMPR1BBMPR1AACVRL1
SCHEMBL21221043 0.83 RIPK1 (0.42) RIPK1ATAD2BMPR1BBMPR1AACVRL1
SCHEMBL21220936 0.83 RIPK1 (0.42) RIPK1ATAD2BMPR1BBMPR1AACVRL1
SCHEMBL21221065 0.76 RIPK1 (0.39) RIPK1
SCHEMBL24094079 0.74 RIPK1 (0.44) RIPK1MAPTHPGDBMPR1BBMPR1A
SCHEMBL13502655 0.72 DRD4 (0.48) RIPK1MAPTHPGDDRD4DRD2
SCHEMBL21220902 0.72 BMPR1B (0.44) RIPK1BMPR1BBMPR1AACVRL1ACVR1
SCHEMBL24094058 0.72 RIPK1 (0.46) RIPK1MAPTHPGDBMPR1AACVRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3526219-B1 BICYCLIC PYRIDONE LACTAMS AND METHODS OF USE THEREOF HOFFMANN LA ROCHE (CH) 2021-12-15 — — EP disclosed
WO-2018073193-A1 BICYCLIC PYRIDONE LACTAMS AND METHODS OF USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2018-04-26 — — WO disclosed
Send feedback